John Paulson (Paulson & Co) trim Madrigal Pharmaceuticals, Inc.
John Paulson (Paulson & Co) trim $632.4M of disclosed value in Madrigal Pharmaceuticals, Inc..
Signal
Investor Move
Action
Trim
Capital
$632.4M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.